521 results match your criteria Chondromyxoid Fibroma


Chondromyxoid Fibroma of the Sacral Spine.

Int J Surg Pathol 2020 May 4:1066896920916784. Epub 2020 May 4.

Rutgers New Jersey Medical School, Newark, NJ, USA.

. Chondromyxoid fibromas are rare tumors of cartilaginous origin typically found in long bones. They usually present during the second and third decades of life. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1066896920916784DOI Listing

Chondromyxoid Fibroma of Distal Phalanx of the Great Toe: A Rare Clinical Entity.

Cureus 2020 Feb 28;12(2):e7133. Epub 2020 Feb 28.

Orthopaedics, Siddhartha Medical College, Vijayawada, IND.

Chondromyxoid fibroma is a rare benign tumor of cartilaginous origin with myxoid and fibrous components. It accounts for approximately 1% of bone tumors. Metaphysis of long bones is the most common location of this tumor. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7759/cureus.7133DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105257PMC
February 2020

Chondromyxoid Fibroma of the Mastoid: A Rare Entity with Comprehensive Literature Review.

J Int Adv Otol 2020 Apr;16(1):117-122

Department of Otorhinolaryngology, University Hospital Antwerp, University of Antwerp, Antwerp, Belgium.

Chondromyxoid fibroma (CMF) is the least commonly occurring bone tumor of cartilaginous origin. It is usually situated in the metaphysis of long bones of the lower limbs. Localization of the tumor in the skull is extremely rare. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5152/iao.2019.6911DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224415PMC
April 2020
0.128 Impact Factor

Chondromyxoid fibroma of the temporal bone: A rare case report.

Medicine (Baltimore) 2020 Mar;99(11):e19487

Department of Otorhinolaryngology, Beijing Tongren Hospital.

Rationale: Chondromyxoid fibroma (CMF) is a rare form of benign bone tumor and easily misdiagnosed as fibrosarcoma. Hence, to explore the clinical manifestations, diagnostic tests, and therapeutic procedures for temporal bone cartilage myxoid fibroma, it is important to optimize patient treatment and avoid overtreatment. Previous research has discussed cases of CMF, but this paper presents a systematic, complete, and comprehensive introduction of this disease based on this case and related literature. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000019487DOI Listing
March 2020
5.723 Impact Factor

Secondary aneurysmal bone cysts and associated primary lesions: imaging features of 49 cases.

Clin Imaging 2020 Jun 30;62:23-32. Epub 2020 Jan 30.

Department of Radiology and Biomedical Imaging, University of California, San Francisco, 505 Parnassus Ave, San Francisco, CA 94143, United States of America.

Purpose: To describe the imaging, anatomic, and clinical features of a series of secondary aneurysmal bone cysts (ABC) and to ascertain their most commonly associated primary bone lesions.

Methods: Forty-nine cases of histopathologically proven secondary ABCs were retrospectively reviewed. Demographic data and clinical history were obtained. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinimag.2020.01.022DOI Listing

Chondromyxoid fibroma-like osteosarcoma: a case series and literature review.

BMC Musculoskelet Disord 2020 Jan 29;21(1):53. Epub 2020 Jan 29.

Department of Imaging, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, 1111 Xian Xia Road, Shanghai, 200050, China.

Background: Chondromyxoid fibroma-like osteosarcoma (CMF-OS) is an exceedingly rare subtype of low-grade central osteosarcoma (LGCO), accounting for up to 10% of cases and making it difficult to diagnose. CMF-OS is frequently misdiagnosed on a radiological examination and biopsy, even after the initial operation. Its treatment is a controversial issue due to its low-grade classification and actual high-grade behavior. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12891-020-3063-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990471PMC
January 2020

Soft Tissue Special Issue: Chondroid Neoplasms of the Skull.

Head Neck Pathol 2020 Mar 16;14(1):83-96. Epub 2020 Jan 16.

Division of Anatomical Pathology, Department of Pathology and Laboratory Medicine, The Ottawa Hospital/University of Ottawa, 501 Smyth Rd, 4th Floor CCW, Room 4250, Ottawa, ON, K1H 8L6, Canada.

Clinically, radiologically, and pathologically, chondroid neoplasms of the skull can be diagnostically challenging due to overlapping features in each of these domains. Compounding the problem for the pathologist, there is also significant morphologic, immunophenotypic, and molecular genetic overlap between benign and malignant cartilaginous lesions, and the majority of these lesions are encountered quite rarely in routine surgical pathology practice. Each of these factors contribute to the diagnostic difficulty posed by these lesions, highlighting the importance of radiologic-pathologic correlation in the diagnosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12105-019-01091-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021846PMC

Utility of FOS as diagnostic marker for osteoid osteoma and osteoblastoma.

Virchows Arch 2020 Mar 25;476(3):455-463. Epub 2019 Nov 25.

Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2333, ZA, Leiden, The Netherlands.

Osteoid osteoma and osteoblastoma are bone-forming tumors shown to harbor FOS (87%) and FOSB (3%) rearrangements. The aim was to evaluate the immunohistochemical expression of FOS and FOSB in these tumors in comparison to other bone tumors, to evaluate the influence of decalcification, and to correlate immunohistochemical findings with the underlying genetic alteration using fluorescence in situ hybridization (FISH). Immunohistochemistry using whole sections was performed on osteoid osteoma (n=23), osteoblastoma (n=22), osteoblastoma-like osteosarcoma (n=3), reactive (n=3), and proliferative (n=11) bone lesions. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-019-02684-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085481PMC
March 2020
2.651 Impact Factor

Primary chondromyxoid fibroma of the orbit: An orbital mass with calcification.

Indian J Ophthalmol 2019 12;67(12):2110-2113

Department of Ophthalmology, Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Primary orbital chondromyxoid fibroma is a rarely reported entity. A 34-year-old lady presented with painless, non-axial proptosis of the left eye of 6 months duration. Orbital imaging showed a supero-temporal mass with calcific foci and bone erosion. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/ijo.IJO_1275_19DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896519PMC
December 2019

Sinonasal Chondromyxoid Fibroma: Case Report and Literature Review.

Cureus 2019 Oct 5;11(10):e5841. Epub 2019 Oct 5.

Department of Otolaryngology - Head and Neck Surgery, Indiana University School of Medicine, Indianapolis, USA.

Chondromyxoid fibroma (CMF) is a rare, benign neoplasm of the chondroid, myxoid, and fibrous tissue. It characteristically affects the lower extremity long bones, although it may rarely arise within the craniofacial skeleton. We report the diagnosis and management of a 31-year-old male with a large, incidentally discovered CMF originating from the sphenoid sinus. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7759/cureus.5841DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830535PMC
October 2019

[Chondromucinous tumors involving craniocerebral slope area: a clinicopathological analysis of eight cases].

Zhonghua Bing Li Xue Za Zhi 2019 Mar;48(3):199-203

Department of Pathology, Henan Provincial People's Hospital, Zhengzhou 450003, China.

To investigate the histological type and clinicopathological characteristics of the craniocerebral slope tumors with chondromucinous features. Retrospective analysis was conducted to analyze chondromucinous tumors in the slope area diagnosed at Henan Provincial People's Hospital from October 2011 to June 2018. Relevant clinical and pathological data were reviewed, and immunohistochemistry was used to investigate the immunophenotype of the tumors. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.issn.0529-5807.2019.03.006DOI Listing
March 2019
10 Reads

Chondromyxoid fibroma of the temporal bone: A case report and review of the literature.

World J Clin Cases 2018 Dec;6(16):1210-1216

Department of Radiology, the Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong Province, China.

Background: Chondromyxoid fibroma (CMF) is a rare benign bone tumour of cartilaginous origin, which usually affects the metaphysis of the long bone. Involvement of the temporal bone is extremely rare. Patients with CMF in the temporal bone can present some neurological deficits due to involvement of surrounding neural structures. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12998/wjcc.v6.i16.1210DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306630PMC
December 2018
8 Reads

Diagnosis and Literature Review of Chondromyxoid Fibroma - A Pathological Puzzle.

J Orthop Case Rep 2019 ;9(4):101-105

Department of Orthopaedics and Traumatology, Rajiv Gandhi Government General Hospital, Chennai, Tamil Nadu, India.

Introduction: Chondromyxoid fibroma (CMF) is a benign rare bone tumor of slow-growing nature arising from chondroblastic derivation. CMF in most of the cases is a diagnosis of exclusion, and in this case report, we differentiate the histological and radiological findings of CMF and difficulties in diagnosis of CMF from potential differential diagnosis.

Case Report: A 38-year-old female patient presented with a history of limping for 5 months and on evaluation revealed an expansile osteolytic lesion in fibular head with septations and soft tissue component. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.13107/jocr.2019.v09.i04.1500DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210904PMC
January 2019

An update of molecular pathology of bone tumors. Lessons learned from investigating samples by next generation sequencing.

Genes Chromosomes Cancer 2019 02 24;58(2):88-99. Epub 2018 Dec 24.

Department of Pathology, The Royal National Orthopaedic Hospital, Stanmore, Middlesex, United Kingdom.

The last decade has seen the majority of primary bone tumor subtypes become defined by molecular genetic alteration. Examples include giant cell tumour of bone (H3F3A p.G34W), chondroblastoma (H3F3B p. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/gcc.22699
Publisher Site
http://dx.doi.org/10.1002/gcc.22699DOI Listing
February 2019
15 Reads

Chondromyxoid fibroma with a secondary aneurysmal bone cyst of the distal radius: A case report.

J Orthop Sci 2018 Dec 20. Epub 2018 Dec 20.

Department of Orthopaedic Surgery, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jos.2018.11.017DOI Listing
December 2018
7 Reads

Chondromyxoid Fibroma of the Pelvis: Institutional Case Series With a Focus on Distinctive Features.

Int J Surg Pathol 2019 Jun 23;27(4):352-359. Epub 2018 Dec 23.

1 Johns Hopkins University, Baltimore, MD, USA.

Chondromyxoid fibroma (CMF) is a relatively uncommon benign bone tumor of cartilaginous differentiation. The primary pitfall in the histopathologic diagnosis of CMF is confusion with a high-grade chondrosarcoma, owing to the atypical stellate and spindled cells set within a chondromyxoid background. CMF is particularly challenging to diagnose within the pelvis, where clinical suspicion for chondrosarcoma is high and benign lesions may grow to a large size to occupy the pelvic bones. Read More

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1066896918820446
Publisher Site
http://dx.doi.org/10.1177/1066896918820446DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504570PMC
June 2019
12 Reads

Surface-type chondromyxoid fibroma in an elderly patient: a case report and literature review.

Skeletal Radiol 2019 May 29;48(5):823-830. Epub 2018 Nov 29.

Department of Musculoskeletal Radiology, NYU Langone Health, New York, NY, USA.

Chondromyxoid fibroma (CMF) is a rare benign bone neoplasm that typically occurs in young adults. Juxtacortical or surface-type CMF are rarer still and we present the case of a surface-type CMF in a 78-year-old woman, with only one other case described in a patient of a similar age previously. This patient was an otherwise healthy woman who presented for evaluation of a palpable lump in the anterior proximal tibia. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00256-018-3120-4DOI Listing
May 2019
8 Reads

Huge chondromyxoid fibroma of the right iliac wing with tremendous soft tissue extensions.

BJR Case Rep 2018 21;4(1):20170014. Epub 2017 Oct 21.

Department of Radiology, Benha University, Benha, Egypt.

This report describes a huge chondromyxoid fibroma (CMF) that developed in the right iliac crest and wing. The tumour is rare, perhaps the rarest of all bone tumours, and its occurrence in the iliac crest and wing of a 63-year-old male is extraordinarily uncommon. The patient complained of gradual onset of right groin pain over a period of more than 2 years and low back pain and tender swelling of the right gluteal region over a period of another 1 year. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1259/bjrcr.20170014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159151PMC
October 2017
32 Reads

Histone H3K36M mutation and trimethylation patterns in chondroblastoma.

Histopathology 2019 Jan 4;74(2):291-299. Epub 2018 Nov 4.

Department of Pathology, Memorial Sloan Kettering Cancer Center, Great Neck, NY, USA.

Aims: Histones are essential components of chromatin, and mutations in histones lead to alterations in methylation and acetylation, which play an important role in tumorigenesis. Most of the chondroblastomas harbour the H3K36M mutation. With the availability of a mutation-specific antibody, we sought to assess the sensitivity of this antibody and the alterations of histone methylation in a series of chondroblastoma cases. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13725DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298805PMC
January 2019
43 Reads

Treatment of cryotherapy and orthotopic transplantation following chondromyxoid fibroma of zygomatic bone: A case report.

Medicine (Baltimore) 2018 Aug;97(31):e11707

Department of Oral, Maxillofacial, Cephalic and Cervical Tumors, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Huangpu District, Shanghai, China.

Introduction: Chondromyxoid fibrotherma (CMF) is a rare benign cartilage tumor that occurs more frequently in young males at the age of 20 to 30. It occurs more frequently on long bones, but rarely involves craniofacial bones.

Case Presentation: This study mainly introduced a 30-year-old male with CMF of zygomatic bone. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000011707DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081066PMC
August 2018
36 Reads

[Effectiveness of unicompartment allografts replacement for bone tumor around the knee].

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2017 08;31(8):908-912

Department of Orthopaedics, General Hospital of Chinese PLA, Beijing, 100853, P.R.China.

Objective: To analyze the effectiveness of unicompartment allografts replacement for reconstructing bone defect after bone tumor resection around knee.

Methods: Between January 2007 and January 2014, a total of 9 patients received unicompartment allografts replacement to treat bone tumor around the knee, including 6 males and 3 females, with an average age of 25.8 years (range, 17-38 years). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7507/1002-1892.201704044DOI Listing
August 2017
8 Reads

A case report on partial scapulectomy with glenoid preservation for Chondromyxoid fibroma of scapula.

J Clin Orthop Trauma 2018 Mar 28;9(Suppl 1):S129-S135. Epub 2017 Dec 28.

Professor, Department of Orthopaedics, Assam Medical College & Hospital, Dibrugarh, Assam, India.

Chondromyxoid fibroma is a benign bone tumour accounting for less than 1% of all primary bone tumours. It usually affects the metaphyseal region of long bones in the first or second decade of life. It rarely occurs in scapula. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcot.2017.12.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883918PMC
March 2018
8 Reads

Fluorescent In Situ Hybridization for TP53 in the Diagnosis of Pediatric Osteogenic Sarcoma.

Am J Surg Pathol 2018 06;42(6):744-749

Division of Pathology.

Osteogenic sarcoma (OS) is the most common malignant bone tumor in children and adolescents. Despite advances in molecular genetic characterization of pediatric and adult tumors, the diagnosis of OS still depends almost entirely on light microscopy. The lack of consistent genetic changes in OS has greatly hindered the development of any diagnostic molecular test. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000001054DOI Listing
June 2018
15 Reads

Peering beneath the surface: Juxtacortical tumors of bone (part I).

Clin Imaging 2018 Sep - Oct;51:1-11. Epub 2018 Feb 3.

Department of Radiology, Cleveland Medical Center, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, OH, USA.

Juxtacortical or surface tumors of bone are neoplasms arising from or just outside the cortex, and are composed of different histologic types. Although the imaging appearances of these lesions have similarities to their intramedullary counterparts, their location alters their radiographic and MR characteristics, creating difficulties in diagnosis. Meanwhile, several non-neoplastic lesions, such as stress reaction/stress fracture and indolent infectious processes, compound the differential diagnosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinimag.2018.01.009DOI Listing
December 2018
60 Reads

Chondromyxoid Fibroma of the Metatarsal Bone: A Diagnosis Using Fine Needle Aspiration Biopsy.

J Cytol 2018 Jan-Mar;35(1):67-68

Department of Orthpaedics, Andaman and Nicobar Islands Institute of Medical Sciences, Port Blair, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/JOC.JOC_48_17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795736PMC
February 2018
7 Reads

Benign Chondromyxoid Fibroma of the Iliac Crest.

J Orthop Sports Phys Ther 2018 02;48(2):122

A 23-year-old woman initiated a running program and after 2 months began experiencing right hip joint pain and sharp pain at the iliac crest. Following evaluation by her primary care physician, she was referred to a physical therapist. Eighteen months later, the patient had developed a bony prominence at the iliac crest that was painful to touch. Read More

View Article

Download full-text PDF

Source
http://www.jospt.org/doi/10.2519/jospt.2018.7551
Publisher Site
http://dx.doi.org/10.2519/jospt.2018.7551DOI Listing
February 2018
14 Reads

Peering beneath the surface: juxtacortical tumors of bone (part II).

Clin Imaging 2018 Jul - Aug;50:113-122. Epub 2018 Jan 11.

Department of Radiology, Cleveland Medical Center, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, OH, USA.

Juxtacortical or surface tumors of bone are neoplasms arising from or just outside the cortex, and are composed of different histologic types. Although the imaging appearances of these lesions have similarities to their intramedullary counterparts, their location alters their radiographic and MR characteristics, creating difficulties in diagnosis. Meanwhile, several non-neoplastic lesions, such as stress reaction/stress fracture and indolent infectious processes, compound the differential diagnosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinimag.2018.01.005DOI Listing
October 2018
28 Reads

Chondromyxoid Fibroma Arising in Craniofacial Sites: A Clinicopathologic Analysis of 25 Cases.

Am J Surg Pathol 2018 03;42(3):392-400

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

Chondromyxoid fibroma (CMF) is a rare benign tumor, usually arising in the metaphysis of long bones in young adults. Occurrence in craniofacial bones presents a particular diagnostic challenge given its unusual location and resemblance to malignant mimics. We describe the clinicopathologic features of 25 cases of craniofacial CMF identified between 1999 and 2017. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000001019DOI Listing
March 2018
17 Reads

Radiological presentation of chondromyxoid fibroma in the sellar region: A CARE-compliant article and literature review.

Medicine (Baltimore) 2017 Dec;96(49):e9049

aDepartment of Neurology, Shengjing Hospital of China Medical University, Shenyang, Liao Ning, ChinabDepartment of Pathology, Duke University Medical Center, Durham, NCcDepartment of Pathology, First Affiliated Hospital of China Medical University and College of Basic Medical Sciences, Shenyang, Liao Ning, China.

Rationale: Chondromyxoid fibroma (CMF) is a rare benign bone neoplasm which often occurs in the lower extremities. Little is known about the radiological and histological presentation of CMF in the sellar region.

Patient Concerns: A 16-year-old Asian male presented to the hospital 12 months ago with bilateral diplopia involving right visual fields, intermittent headaches, and dizziness. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000009049DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728922PMC
December 2017
27 Reads

Preliminary Exploration of the Diagnosis and Treatment of Skull-Based Chondromyxoid Fibromas.

Oper Neurosurg (Hagerstown) 2018 09;15(3):270-277

Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.

Background: Chondromyxoid fibromas (CMFs) are benign tumors that occur rarely in the skull base.

Objective: To conduct a preliminary exploration of the diagnosis and treatment of cranial CMFs.

Methods: A retrospective analysis of 19 cases of CMFs in the base of the skull between 2009 and 2014 in our hospital was conducted. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ons/opx233DOI Listing
September 2018
7 Reads

Long-lasting chondromyxoid fibroma of the zygoma: A rare case report and review of literature.

J Educ Health Promot 2017 9;6:78. Epub 2017 Aug 9.

Department of Otolaryngology, Clinical Pathology Division, Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Chondromyxoid fibroma (CMF) is a benign tumor which usually occurs in skeletal long bones. Its presence in zygoma is extremely rare. The patient was a 47-year-old female, with chief complaint of painful swelling in the left side of zygoma since 1 month ago after a long-lasting painless swelling for about 15 years. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/jehp.jehp_33_17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561685PMC
August 2017
23 Reads

An intracortical chondromyxoid fibroma in the diaphysis of the metatarsal.

Skeletal Radiol 2017 Dec 15;46(12):1757-1762. Epub 2017 Aug 15.

Department of Pathology, Korea University Ansan Hospital, Ansan-si, Republic of Korea.

Chondromyxoid fibromas (CMFs) are rare, benign, primary tumors of bones, and occur in the metaphyses of the medullary canals of the long bones. The occurrence of intracortical CMFs is extremely rare. Very few cases of intracortical CMFs located in the long tubular bones have been reported to date. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00256-017-2743-1DOI Listing
December 2017
12 Reads

Chondromyxoid fibroma of the distal fibula treated by percutaneous radiofrequency ablation.

J Orthop Surg (Hong Kong) 2017 May-Aug;25(2):2309499017720830

4 Department of Orthopedic Surgery, Hadassah-Hebrew University School of Medicine, Shaare Zedek Medical Center, Jerusalem, Israel.

Background: Percutaneous radiofrequency ablation (RFA) has been shown to be an effective treatment for soft tissue lesions and also benign bone tumors, especially osteoid osteoma. There are limited data regarding this technique in other bone tumors, specifically larger and more aggressive ones.

Purposes: To describe the use of RFA as a definitive treatment and an alternative to traditional open surgery for the treatment of chondromyxoid fibroma (CMF), a benign but locally aggressive bone tumor. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2309499017720830DOI Listing
March 2018
11 Reads

[Rare location of chondromyxoid fibroma: about a case].

Pan Afr Med J 2017;26:219. Epub 2017 Apr 24.

Service de Chirurgie Orthopédique et de Traumatologie, CHU Ibn Sina, Université Mohammed V Souissi, Rabat, Maroc.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.11604/pamj.2017.26.219.12289DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491748PMC
February 2018
11 Reads

Phosphaturic Mesenchymal Tumors: Clinicopathologic, Immunohistochemical and Molecular Analysis of 22 Cases Expanding their Morphologic and Immunophenotypic Spectrum.

Am J Surg Pathol 2017 Oct;41(10):1371-1380

*Institute of Pathology ††Department of Hand & Plastic Surgery, University Hospital, Erlangen **Institute of Pathology ‡‡Department of Orthopedic & Traumatology, Section for Tumor Orthopedics, University Hospital, Bonn, Germany †Department of Pathology, Faculty of Medicine in Pilsen, Charles University, Prague ‡Biomedical Center of the Faculty of Medicine in Pilsen, Pilsen, Czech Republic §Department of Pathology, University of Pittsburgh Medical Center, Presbyterian Hospital, Pittsburgh, PA ∥Department of Pathology, National University Health System, Singapore ¶Department of Pathology, 3rd Medical Faculty in Prague, Charles University, Prague, Czech Republic.

Phosphaturic mesenchymal tumor (PMT) is a rare neoplasm of uncertain histogenesis that has been linked to tumor-induced osteomalacia (TIO) since 1959. The neoplastic cells produce increased amount of FGF23 which results in TIO via uncontrolled renal loss of phosphate (phosphaturia), and consequently diminished bone mineralization. To date, ∼300 cases have been reported. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000890DOI Listing
October 2017
58 Reads

Benign Bone Conditions That May Be FDG-avid and Mimic Malignancy.

Semin Nucl Med 2017 07 12;47(4):322-351. Epub 2017 Apr 12.

Department of Radiology and Nuclear Medicine, Deventer Ziekenhuis, Deventer, The Netherlands.

Positron emission tomography with the radiotracer F-fluoro-2-deoxy-d-glucose (FDG) plays an important role in the evaluation of bone pathology. However, FDG is not a cancer-specific agent, and knowledge of the differential diagnosis of benign FDG-avid bone alterations that may resemble malignancy is important for correct patient management, including the avoidance of unnecessary additional invasive tests such as bone biopsy. This review summarizes and illustrates the spectrum of benign bone conditions that may be FDG-avid and mimic malignancy, including osteomyelitis, bone lesions due to benign systemic diseases (Brown tumor, Erdheim-Chester disease, Gaucher disease, gout and other types of arthritis, Langerhans cell histiocytosis, and sarcoidosis), benign primary bone lesions (bone cysts, chondroblastoma, chondromyxoid fibroma, desmoplastic fibroma, enchondroma, giant cell tumor and granuloma, hemangioma, nonossifying fibroma, and osteoid osteoma and osteoblastoma), and a group of miscellaneous benign bone conditions (post bone marrow biopsy or harvest status, bone marrow hyperplasia, fibrous dysplasia, fractures, osteonecrosis, Paget disease of bone, particle disease, and Schmorl nodes). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.semnuclmed.2017.02.004DOI Listing
July 2017
61 Reads

[Chondromyxoid fibroma of the mandible: a case report].

Hua Xi Kou Qiang Yi Xue Za Zhi 2016 Dec;34(6):654-656

Dept. of Oral and Maxillofacial Surgery, General Hospital of Ningxia Medical University, Yinchuan 750004, China.

Chondromyxoid fibroma (CMF) is a rare benign bone tumor. This tumor mostly affects the long bones of the appendicular skeleton but rarely grows in the craniofacial region. In this article, a case of CMF of the mandible was presented to enhance our understanding of CMF. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7518/hxkq.2016.06.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7030853PMC
December 2016
22 Reads

Chondromyxoid Fibroma of the Skull Base: Our Experience with an Elusive Disease.

J Neurol Surg A Cent Eur Neurosurg 2017 Nov 2;78(6):576-581. Epub 2017 Mar 2.

Rome Army Hospital "Celio," Neurosurgery Division, Sapienza University Rome, Dipartimento Scienze Neurosensoriali, Rome, Italy.

Chondromyxoid fibroma (CMF) is an extremely rare lesion of the skull base. This histologic type typically predilects metaphysis of the long bones. It is locally invasive/infiltrative, and this tendency is more concerning in the skull base, where a radical resection is often technically impossible because of the presence of vital neurovascular structures. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0037-1599137DOI Listing
November 2017
38 Reads

Primary Orbital Chondromyxoid Fibroma: A Rare Case.

Ophthalmic Plast Reconstr Surg 2017 May/Jun;33(3S Suppl 1):S114-S116

Departments of *Ophthalmology and †Neurosurgery, Maywood, Illinois, U.S.A.

A 56-year-old male with history of chronic sinusitis was found to have a 3 cm left orbital lesion on CT. Subsequent MRI demonstrated a multilobulated enhancing soft tissue lesion at the superotemporal region of the left orbit. Initial biopsy was reported as a low-grade sarcoma. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IOP.0000000000000857DOI Listing
September 2017
25 Reads

Exceptional Rare Giant Craniofacial Chondroid Tumor in Adult.

World Neurosurg 2017 Feb 18;98:867.e1-867.e3. Epub 2016 Dec 18.

Department of Neurosurgery, West China Hospital of Sichuan University, Chengdu, Sichuan, China. Electronic address:

We present a rare case of giant soap bubble-shaped cystic lesion in the craniofacial region in an adult female. Histopathologic examination revealed the tumor consisted of 3 components including chondroblastoma, chondromyxoid fibroma, and hemorrhagic aneurysmal bone cyst. The present case is rare in terms of size, location, and histopathologic diagnosis, which is probably the result of underdeveloped health care in the remote place. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2016.12.032DOI Listing
February 2017
37 Reads

Pediatric Chondromyxoid Fibroma-Like Osteosarcoma.

Fetal Pediatr Pathol 2017 Apr 9;36(2):154-161. Epub 2016 Dec 9.

a Department of Pathology , Children's Hospital New Orleans , New Orleans , LA , USA.

Chondromyxoid fibroma-like osteosarcoma (CMF-OS) is a low-grade osteosarcoma, often misdiagnosed on initial biopsy as a benign lesion, with five cases previously described. We report a 13-year-old male with an intramedullary lytic CMF-OS of the right tibial proximal metaphysis with cortical destruction and soft tissue extension. Diagnosis was based on malignant new bone formation, increased mitotic figures, lamellar bone permeation with bony destruction, and correlation with imaging studies. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/15513815.2016.1
Publisher Site
http://dx.doi.org/10.1080/15513815.2016.1259376DOI Listing
April 2017
16 Reads

Chondromyxoid Fibroma: A Rare Case Report and Review of Literature.

Cureus 2016 Sep 23;8(9):e803. Epub 2016 Sep 23.

Orthopaedics, Sumandeep Vidyapeeth, Vadodara, Gujarat.

Chondromyxoid fibroma (CMF) is one of the rarest benign tumors of cartilaginous origin. It accounts for less than 0.5% of bone tumors and less than two percent of benign bone tumors. Read More

View Article

Download full-text PDF

Source
http://www.cureus.com/articles/5287-chondromyxoid-fibroma-a-
Publisher Site
http://dx.doi.org/10.7759/cureus.803DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101078PMC
September 2016
24 Reads

Cytodiagnosis of ChondromyxoidFibroma of the Metatarsal Head: A Case Report.

Iran J Pathol 2016 ;11(3):272-275

Dept. of Pathology, JN Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.

Chondromyxoid fibroma (CMF) is a rare benign cartilaginous tumor with a predilection for the bones of lower extremities and about one fourth of the tumors involve the foot. Radiologically, an eccentric lytic lesion with well-defined margins is seen in the metaphysis of the bone. We hereby, report an 18 yr old young male who presented to Orthopedic Outpatient Department, JN Medical College, Aligarh Muslim University, India diagnosed with giant cell tumor of the third metatarsal bone of right foot on radiography but on fine needle aspiration cytology (FNAC) the diagnosis of CMF was made. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079461PMC
January 2016
8 Reads

Decalcified allograft in repair of lytic lesions of bone: A study to evolve bone bank in developing countries.

Indian J Orthop 2016 Jul-Aug;50(4):427-33

Department of Orthopaedics, Ganesh Shankar Vidyarthi Memorial Medical College, Kanpur, Uttar Pradesh, India.

Background: The quest for ideal bone graft substitutes still haunts orthopedic researchers. The impetus for this search of newer bone substitutes is provided by mismatch between the demand and supply of autogenous bone grafts. Bone banking facilities such as deep frozen and freeze-dried allografts are not so widely available in most of the developing countries. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0019-5413.185609DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964777PMC
August 2016
9 Reads

Chondromyxoid Fibroma of Radius: A Case Report.

J Clin Diagn Res 2016 May 1;10(5):ED01-2. Epub 2016 May 1.

Professor, Department of Pathology, B.L.D.E.U'S Shri B.M. Patil Medical College Hospital and Research Centre , Vijayapur, India .

Chondromyxoid fibroma (CMF) is a rare benign cartilaginous tumour accounting to less than 1% of bone tumours. It is most commonly seen in lower extremity involving tibia. CMF of radius is rare. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7860/JCDR/2016/17967.7728DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948408PMC
May 2016
5 Reads

Chondromyxoid fibroma of the sacrum: A case report and literature review.

Surg Neurol Int 2016 17;7(Suppl 13):S370-4. Epub 2016 May 17.

Department of Neurosurgery, Arrowhead Regional Medical Center, Colton, CA, USA; Department of Neurosurgery, Kaiser Permanente Fontana Medical Center, Fontana, CA, USA.

Background: Chondromyxoid fibroma (CMF) is an extremely rare, benign cartilaginous tumor that makes up <0.5% of all bone tumors, typically presenting in the second or third decade of life. CMF of the sacrum is exceedingly rare, with only seven documented cases reported in the neurosurgical literature. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/2152-7806.182547DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879845PMC
June 2016
75 Reads

[EFFICACY OF BIOACTIVE GLASS AND ALLOGENIC BONE IN REPAIR OF BONE DEFECT AFTER BENIGN BONE TUMOR CURETTAGE].

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2016 Jun;30(6):675-679

Department of Orthopaedic Oncology Surgery, Beijing Jishuitan Hospital, Beijing, 100035, P.R.China.

Objective: To compare the healing process and clinical results of bioactive glass and allogenic bone in the repair of bone defects after benign bone tumor curettage.

Methods: Between November 2011 and December 2012, 20 patients with benign bone tumor received bioactive glass and allogenic bone for repair of bone defects after benign bone tumor curettage. There were 17 males and 3 females, aged 9-68 years (median, 18. Read More

View Article

Download full-text PDF

Source
http://www.rrsurg.com/article/10.7507/1002-1892.20160137
Publisher Site
http://dx.doi.org/10.7507/1002-1892.20160137DOI Listing
June 2016
11 Reads

Imaging features of chondromyxoid fibroma: report of 15 cases and literature review.

Br J Radiol 2016 Aug 26;89(1064):20160088. Epub 2016 May 26.

2 Department of Pathology, University Hospital Leuven and KU Leuven, Leuven, Belgium.

Objective:: Chondromyxoid fibroma (CMF) is a rare benign bony tumour. Our objectives are three-fold: first, comparing MRI, conventional radiography (CR) and CT characteristics of CMF; second, providing a literature review; and third, summarizing the role of imaging landmarks in the differential diagnosis with other bony lesions.

Methods:: 15 patients with histopathologically proven CMF were retrospectively included. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1259/bjr.20160088DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124884PMC
August 2016
9 Reads